Inflammatory Bowel Disease in the Pediatric Patient

Surgical Clinics of North America

Volumn 87, Issue 3, 2007, Pages 643-658

  Ponsky, Todd ^a   Hindle, Anna ^b   Sandler, Anthony ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL ABSCESS; ACNE; ANAL COMPLAINT; CHILD CARE; COLONOSCOPY; CROHN DISEASE; CUSHING SYNDROME; DRUG MEGADOSE; ENTERITIS; ENVIRONMENTAL FACTOR; FISTULA; GENETIC PREDISPOSITION; GINGIVA HYPERPLASIA; HEREDITY; HUMAN; HYPERTENSION; INCIDENCE; INFECTION; INTESTINE FUNCTION; KIDNEY FAILURE; LEUKOPENIA; LIVER TOXICITY; MOON FACE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; REVIEW; SEIZURE; SIDE EFFECT; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREMOR; ULCERATIVE COLITIS; WEIGHT GAIN; WOUND HEALING IMPAIRMENT;

CHILD; HUMANS; INFLAMMATORY BOWEL DISEASES; PEDIATRICS;

EID: 34249864158     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2007.03.002     Document Type: Review

References (99)

1. Cohen M., Seldman E., Winter H., et al. Controversies in pediatric inflammatory bowel disease. Inflamm Bowel Dis 4 (1998) 203-227
2. Mamula P., Markowitz J.E., and Baldassano R.N. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 32 3 (2003) 967-995
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
4. Logan R. Inflammatory bowel disease incidence: up, down or unchanged?. Gut 42 (1998) 309-311
5. Yang E., Johnson S., and Ziegler M. Inflammatory bowel disease and intestinal cancer. In: Ashcraft K., Holcomb G., and Murphy J. (Eds). Pediatric surgery (2005), Elsevier Saunders, Philadelphia
6. Tysk C., Lindberg E., Jarnerot G., et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29 (1988) 990-996 p. 558-76
7. Gilat T., Hacohen D., Lilos P., et al. Childhood factors in ulcerative colitis and Crohn's disease: an international cooperative study. Scand J Gastroenterol 22 (1987) 1009-1024
8. Roth M., Petersen G., McElree C., et al. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 97 (1989) 900-904
9. Hugot J., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 6837 (2001) 599-603
10. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 5804 (2006) 1461-1463
11. Bernstein C.N., Rawsthorne P., Cheang M., et al. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 101 5 (2006) 993-1002
12. Danese S., Sans M., and Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 3 5 (2004) 394-400
13. Koutroubakis I., Manousos O.N., Meuwissen S.G., et al. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 43 8 (1996) 381-393
14. Kugathasan S., Judd R., Khan F., et al. Epidemiologic and clinical characteristics of newly diagnosed inflammatory bowel disease in children in the state of Wisconsin: results of a prospective state wide population based study. J Pediatr Gastroenterol Nutr 35 (2002) A421
15. Farmer R., Easley K., and Rankin G. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 38 (1993) 1137-1146
16. Mir-Madjlessi S., Michener W., and Farmer R. Course and prognosis of idiopathic ulcerative proctosigmoiditis in young patients. J Pediatr Gastroenterol Nutr 5 (1986) 571-575
17. Baldassano R., and Piccoli D. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 28 (1999) 445-458
18. Fish D., and Kugathasan S. Inflammatory bowel disease. Adolesc Med Clin 15 1 (2004) 67-90
19. Ruemmele F.M., Targan S.R., Levy G., et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115 4 (1998) 822-829
20. Kane S.V., Cohen R.D., Aikens J.E., et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 96 10 (2001) 2929-2933
21. Faubion Jr. W.A., Loftus Jr. E.V., Harmsen W.S., et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121 2 (2001) 255-260
22. Lichtiger S., Present D.H., Kornbluth A., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330 26 (1994) 1841-1845
23. Jani N., and Regueiro M.D. Medical therapy for ulcerative colitis. Gastroenterol Clin North Am 31 1 (2002) 147-166
24. Friedman S. General principles of medical therapy of inflammatory bowel disease. Gastroenterol Clin North Am 33 2 (2004) 191-208 viii
25. Garcia-Lopez S., Gomollon-Garcia F., and Perez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol Hepatol 28 10 (2005) 607-614
26. Buchmiller-Crair T. Ulcerative colitis. In: Oldham K., et al. (Ed). Principles and practice of pediatric surgery (2005), Lippincott, Williams & Wilkins, Philadelphia 1365-1380
27. Hanauer S.B. New lessons: classic treatments, expanding options in ulcerative colitis. Colorectal Dis 8 Suppl 1 (2006) 20-24
28. Kane S., Huo D., Aikens J., and Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 114 1 (2003) 39-43
29. George J., Present D.H., Pou R., et al. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 91 9 (1996) 1711-1714
30. Mantzaris G.J., Sfakianakis M., Archavlis E., et al. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis. Am J Gastroenterol 99 6 (2004) 1122-1128
31. Sandborn W.J. Azathioprine: state of the art in inflammatory bowel disease. Scand J Gastroenterol Suppl 225 (1998) 92-99
32. Hibi T., Naganuma M., Kitahora T., et al. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol 38 8 (2003) 740-746
33. Bousvaros A., Kirschner B.S., Werlin S.L., et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr 137 6 (2000) 794-799
34. Sands B.E., Tremaine W.J., Sandborn W.J., et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 7 2 (2001) 83-88
35. Kaser A., Mairinger T., Vogel W., et al. Infliximab in severe steroid-refractory ulcerative colitis: a pilot study. Wien Klin Wochenschr 113 23-24 (2001) 930-933
36. Chey W.Y., Hussain A., Ryan C., et al. Infliximab for refractory ulcerative colitis. Am J Gastroenterol 96 8 (2001) 2373-2381
37. Chang J.C., and Cohen R.D. Medical management of severe ulcerative colitis. Gastroenterol Clin North Am 33 2 (2004) 235-250 viii
38. Sher M.E., Weiss E.G., Nogueras J.J., et al. Morbidity of medical therapy for ulcerative colitis: what are we really saving?. Int J Colorectal Dis 11 6 (1996) 287-293
39. Befrits R., Hammarberg C., Rubio C., et al. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum 37 4 (1994) 313-319 [discussion: 319-20]
40. Devroede G.J., Taylor W.F., Sauer W.G., et al. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 285 1 (1971) 17-21
41. McNevin M.S., Bax T., MacFarlane M., et al. Outcomes of a laparoscopic approach for total abdominal colectomy and proctocolectomy. Am J Surg 191 5 (2006) 673-676
42. Marcello P.W., Milsom J.W., Wong S.K., et al. Laparoscopic restorative proctocolectomy: case-matched comparative study with open restorative proctocolectomy. Dis Colon Rectum 43 5 (2000) 604-608
43. Bernstein C.N. Neoplasia in inflammatory bowel disease: surveillance and management strategies. Curr Gastroenterol Rep 8 6 (2006) 513-518
44. Chambers W.H., Warren B.F., Jewell D.P., et al. Cancer surveillance in ulcerative colitis. Br J Surg 92 8 (2005) 928-936
45. Khorrami Mashhadi S., Trapero M., Gisbert J.P., et al. A pilot study on the endoscopic surveillance of colorectal dysplasia and cancer in long-standing ulcerative colitis. Rev Esp Enferm Dig 97 1 (2005) 16-23
46. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 53 12 (2004) 1813-1816
47. Kiesslich R., and Neurath M.F. Chromoendoscopy and other novel imaging techniques. Gastroenterol Clin North Am 35 3 (2006) 605-619
48. Jimmo B., and Hyman N.H. Is ileal pouch-anal anastomosis really the procedure of choice for patients with ulcerative colitis?. Dis Colon Rectum 41 1 (1998) 41-45
49. Lichtenstein G.R., Cohen R., Yamashita B., et al. Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. J Clin Gastroenterol 40 8 (2006) 669-677
50. Nicholls R.J., Holt S.D., and Lubowski D.Z. Restorative proctocolectomy with ileal reservoir. Comparison of two-stage vs. three-stage procedures and analysis of factors that might affect outcome. Dis Colon Rectum 32 4 (1989) 323-326
51. Rintala R.J., and Lindahl H. Restorative proctocolectomy for ulcerative colitis in children-is the J-pouch better than straight pull-through?. J Pediatr Surg 31 4 (1996) 530-533
52. Taylor B.M., Beart Jr. R.W., Dozois R.R., et al. Straight ileoanal anastomosis v ileal pouch-anal anastomosis after colectomy and mucosal proctectomy. Arch Surg 118 6 (1983) 696-701
53. Stoller D.K., Coran A.G., Drongowski R.A., et al. Physiologic assessment of the four commonly performed endorectal pullthroughs. Ann Surg 206 5 (1987) 586-594
54. Tonelli F., Batignani G., Ficari F., et al. Straight ileoanal anastomosis with multiple ileal myotomies as an alternative to pelvic pouch. Int J Colorectal Dis 12 5 (1997) 261-266
55. Landi E., Landa L., Fianchini A., et al. Straight ileo-anal anastomosis with myectomy as an alternative to ileal pouch-anal anastomosis in restorative proctocolectomy. Int J Colorectal Dis 9 1 (1994) 45-49
56. Umehara Y., Kudo M., Nakaoka R., et al. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepatogastroenterology 53 72 (2006) 879-882
57. Ambrosini R., Barchiesi A., Di Mizio V., et al. Inflammatory chronic disease of the colon: how to image. Eur J Radiol 61 3 (2006) 442-448
58. Haykir R., Karakose S., Karabacakoglu A., et al. Three-dimensional MR and axial CT colonography versus conventional colonoscopy for detection of colon pathologies. World J Gastroenterol 12 15 (2006) 2345-2350
59. Mackalski B.A., and Bernstein C.N. New diagnostic imaging tools for inflammatory bowel disease. Gut 55 5 (2006) 733-741
60. Leighton J.A., and Loftus Jr. E.V. Evolving diagnostic modalities in inflammatory bowel disease. Curr Gastroenterol Rep 7 6 (2005) 467-474
61. Su C., Salzberg B.A., Lewis J.D., et al. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 97 10 (2002) 2577-2584
62. Sanders D.S. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol 58 6 (2005) 568-572
63. Hanauer S.B. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12 Suppl 1 (2006) S3-S9
64. Abraham C., and Cho J.H. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis 12 7 (2006) 641-650
65. Curran M.E., Lau K.F., Hampe J., et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 115 5 (1998) 1066-1071
66. Hampe J., Grebe J., Nikolaus S., et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359 9318 (2002) 1661-1665
67. Newman B., and Siminovitch K.A. Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 21 4 (2005) 401-407
68. Hampe J., Cuthbert A., Croucher P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 9272 (2001) 1925-1928
69. Sawczenko A., and Sandhu B.K. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 88 11 (2003) 995-1000
70. Beattie R.M., Croft N.M., Fell J.M., et al. Inflammatory bowel disease. Arch Dis Child 91 5 (2006) 426-432
71. Caprilli R., Gassull M.A., Escher J.C., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 55 Suppl 1 (2006) i36-i58
72. Vermeire S., Van Assche G., and Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 55 3 (2006) 426-431
73. Yantiss R.K., and Odze R.D. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology 48 2 (2006) 116-132
74. Egan L.J., and Sandborn W.J. Advances in the treatment of Crohn's disease. Gastroenterology 126 6 (2004) 1574-1581
75. Lowney J.K., Dietz D.W., Birnbaum E.H., et al. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study. Dis Colon Rectum 49 1 (2006) 58-63
76. Fichera A., McCormack R., Rubin M.A., et al. Long-term outcome of surgically treated Crohn's colitis: a prospective study. Dis Colon Rectum 48 5 (2005) 963-969
77. Farmer R.G., Whelan G., and Fazio V.W. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 88 6 (1985) 1818-1825
78. Kotanagi H., Kramer K., Fazio V.W., et al. Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn's disease? Retrospective analysis of 100 cases. Dis Colon Rectum 34 10 (1991) 909-916
79. Heimann T.M., Greenstein A.J., Lewis B., et al. Prediction of early symptomatic recurrence after intestinal resection in Crohn's disease. Ann Surg 218 3 (1993) 294-298 [discussion: 298-9]
80. Pennington L., Hamilton S.R., Bayless T.M., et al. Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg 192 3 (1980) 311-318
81. Sampietro G.M., Cristaldi M., Maconi G., et al. A prospective, longitudinal study of nonconventional strictureplasty in Crohn's disease. J Am Coll Surg 199 1 (2004) 8-20 [discussion: 20-2]
82. Diamond I.R., and Langer J.C. Laparoscopic-assisted versus open ileocolic resection for adolescent Crohn disease. J Pediatr Gastroenterol Nutr 33 5 (2001) 543-547
83. von Allmen D., Markowitz J.E., York A., et al. Laparoscopic-assisted bowel resection offers advantages over open surgery for treatment of segmental Crohn's disease in children. J Pediatr Surg 38 6 (2003) 963-965
84. Bonnard A., Fouquet V., Berrebi D., et al. Crohn's disease in children. Preliminary experience with a laparoscopic approach. Eur J Pediatr Surg 16 2 (2006) 90-93
85. Bemelman W.A., Slors J.F., Dunker M.S., et al. Laparoscopic-assisted vs. open ileocolic resection for Crohn's disease. A comparative study. Surg Endosc 14 8 (2000) 721-725
86. Young-Fadok T.M., HallLong K., McConnell E.J., et al. Advantages of laparoscopic resection for ileocolic Crohn's disease. Improved outcomes and reduced costs. Surg Endosc 15 5 (2001) 450-454
87. Milsom J.W., Hammerhofer K.A., Bohm B., et al. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease. Dis Colon Rectum 44 1 (2001) 1-8 [discussion: 8-9]
88. Triester S.L., Leighton J.A., Leontiadis G.I., et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Am J Gastroenterol 101 5 (2006) 954-964
89. Kim J., Kim Y.S., Chun H.J., et al. Laparoscopy-assisted exploration of obscure gastrointestinal bleeding after capsule endoscopy: the Korean experience. J Laparoendosc Adv Surg Tech A 15 4 (2005) 365-373
90. Garcia J.C., Persky S.E., Bonis P.A., et al. Abscesses in Crohn's disease: outcome of medical versus surgical treatment. J Clin Gastroenterol 32 5 (2001) 409-412
91. Ayuk P., Williams N., Scott N.A., et al. Management of intra-abdominal abscesses in Crohn's disease. Ann R Coll Surg Engl 78 1 (1996) 5-10
92. Gutierrez A., Lee H., and Sands B.E. Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease. Am J Gastroenterol 101 10 (2006) 2283-2289
93. Sahai A., Belair M., Gianfelice D., et al. Percutaneous drainage of intra-abdominal abscesses in Crohn's disease: short and long-term outcome. Am J Gastroenterol 92 2 (1997) 275-278
94. Danelli P., Bartolucci C., Sampietro G.M., et al. [Surgical options in the treatment of perianal Crohn's disease]. Ann Ital Chir 74 6 (2003) 635-640
95. Hyder S.A., Travis S.P., Jewell D.P., et al. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 49 12 (2006) 1837-1841
96. Asteria C.R., Ficari F., Bagnoli S., et al. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand J Gastroenterol 41 9 (2006) 1064-1072
97. Regueiro M., and Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 9 2 (2003) 98-103
98. Osterman M.T., and Lichtenstein G.R. Infliximab in fistulizing Crohn's disease. Gastroenterol Clin North Am 35 4 (2006) 795-820
99. Poritz L.S., Rowe W.A., and Koltun W.A. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum 45 6 (2002) 771-775